These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28800150)

  • 21. Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon.
    Shiraga M; Miyata S; Kato H; Kashiwagi H; Honda S; Kurata Y; Tomiyama Y; Kanakura Y
    J Thromb Haemost; 2005 Oct; 3(10):2315-23. PubMed ID: 16194207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose aspirin in dogs increases vascular resistance with limited additional anti-platelet effect when combined with potent P2Y12 inhibition.
    Björkman JA; Zachrisson H; Forsberg GB; von Bahr H; Hansson GI; Warner TD; Nylander S
    Thromb Res; 2013 Apr; 131(4):313-9. PubMed ID: 23419412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
    Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
    Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
    Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
    Scavone M; Germanovich K; Femia EA; Cattaneo M
    Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion model.
    Bhal V; Herr MJ; Dixon M; Akins S; Hord E; White MM; Seiffert D; Kotha J; Jennings LK
    Thromb Res; 2015 Dec; 136(6):1216-23. PubMed ID: 26412559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
    Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
    J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y
    Gündüz D; Tanislav C; Sedding D; Parahuleva M; Santoso S; Troidl C; Hamm CW; Aslam M
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.
    O'Connor SA; Amour J; Mercadier A; Martin R; Kerneis M; Abtan J; Brugier D; Silvain J; Barthélémy O; Leprince P; Montalescot G; Collet JP;
    Circ Cardiovasc Interv; 2015 Nov; 8(11):e002786. PubMed ID: 26553698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a P2Y
    Amann M; Ferenc M; Valina CM; Bömicke T; Stratz C; Leggewie S; Trenk D; Neumann FJ; Hochholzer W
    Platelets; 2016 Nov; 27(7):668-672. PubMed ID: 27065056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
    Brassard JA; Meyers KM
    Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
    Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
    Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding.
    Mundell SJ; Rabbolini D; Gabrielli S; Chen Q; Aungraheeta R; Hutchinson JL; Kilo T; Mackay J; Ward CM; Stevenson W; Morel-Kopp MC
    J Thromb Haemost; 2018 Jan; 16(1):44-53. PubMed ID: 29117459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Underlying mechanism and specific prevention of hemolysis-induced platelet activation.
    Gremmel T; Fedrizzi S; Weigel G; Eichelberger B; Panzer S
    Platelets; 2017 Sep; 28(6):555-559. PubMed ID: 27848264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of adenosine 5'-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis.
    Pelagalli A; Ciaramella P; Lombardi P; Pero ME; Cortese L; Corona M; Oliva G; Avallone L
    J Comp Pathol; 2004; 130(2-3):124-9. PubMed ID: 15003469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.